Skip to the page

Data / Public companies / SIC 5122: Wholesale, drugs, proprietaries and druggists' sundries / Cardinal Health Inc

Cardinal Health Inc: revenue, net income and total assets from its latest annual report

Updated August 11, 2026. Source: SEC Financial Statement Data Sets, filing 0000721371-26-000038.

Cardinal Health Inc reported revenue of $254.25 billion, net income of $1.71 billion and total assets of $57.30 billion for the fiscal year ended June 30, 2026, in its annual report (10-K) filed with the SEC on August 11, 2026. It ranks 3rd by revenue of 11 companies in SIC 5122, wholesale, drugs, proprietaries and druggists' sundries.

The request: Watch Cardinal Health Inc (CIK 721371): each new SEC filing, with revenue and net income. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the annual reports that companies file with the SEC, and this page is that reading. Ask for the companies of an industry, state or city with their website, number of employees and funding added from the web, and each new annual report arrives in your sheet, CRM, Slack or agent as the SEC posts it.

SEC central index key (CIK)
721371
Industry
SIC 5122, Wholesale, drugs, proprietaries and druggists' sundries
Business address (city and state)
Dublin, Ohio
Incorporated in
Ohio
Filer category
Large accelerated filer
Fiscal year ends
June 30
Latest annual report
10-K filed August 11, 2026
Annual and quarterly reports in the data
2 annual, 3 quarterly

Financials for the fiscal year ended June 30, 2026

As filed, in US dollars. The prior year value is the comparison column in the same report.

ItemThis yearPrior yearChangeSource
Revenue$254,248,000,000$222,578,000,00014.2%sec.gov
Operating income$2,613,000,000Not listedNot listedsec.gov
Net income$1,714,000,000$1,561,000,0009.8%sec.gov
Total assets$57,299,000,000$53,122,000,0007.9%sec.gov
Stockholders' equity$-2,883,000,000Not listedNot listedsec.gov
Cash and cash equivalents$4,856,000,000Not listedNot listedsec.gov

How it compares

Net margin (net income over revenue)
0.7%
Revenue change on the prior year
14.2%
Revenue rank in SIC 5122
3rd of 11
Revenue rank in Ohio
1st of 100
Revenue rank among all companies in the data
14th of 4,486

Companies next to it by revenue in SIC 5122

Wholesale, drugs, proprietaries and druggists' sundries, from the same data.

CompanyBusiness addressRevenueNet incomeTotal assetsRevenue change
McKesson CorpIrving, TX$403.43 billion$4.76 billion$82.32 billion12.4%
Cencora, Inc.Conshohocken, PA$321.33 billion$1.55 billion$76.59 billion9.3%
Herbalife LTD.George Town, Cayman Islands$5.04 billion$228.3 million$2.79 billion0.9%
Nu Skin Enterprises, Inc.Provo, UT$1.49 billion$160.2 million$1.41 billion-14.3%
Cosmos Health Inc.Thessaloniki, Greece$65.3 million$-19,144,998$65.5 million19.9%
Zerostack Corp.Toronto$35.7 million$-119,732,000$130.2 million-0.5%
Wellgistics Health, Inc.Tampa, FL$23.3 million$-101,274,530$30.5 million28.7%
Stemtech CorpNaples, FL$2.9 million$-4,046,705$3.1 million-43.1%

Public data from the US Securities and Exchange Commission. Companies are the registrants whose latest annual report (form 10-K, 20-F or 40-F) is in the SEC Financial Statement Data Sets for 2025 Q3 to 2026 Q3, filed through September 30, 2026. Figures are for the whole fiscal year of that report, in US dollars, as the company filed them in XBRL: SpecStream does not adjust them. The SEC does not guarantee the data sets, and they do not replace the filings. Revenue is the revenue tag the company used; banks and funds often use none. Combined totals add each company once and can include a parent and its subsidiary that both file. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.